mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |